First Line UFT, OXALIPLATIN and ERBITUX combination (TEGAFOX-E) in Elderly (≥ 70 years) metastatic colorectal patients: a Phase II ITMO study.

ABSTRACT: Primary objectives: To assess the respons rate ORR (CR+PR)

DISEASE(S): Metastatic Colorectal Cancer,Metastatic Adenocarcinoma Of Colon Or Rectum

PROVIDER: 2524137 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR